Cognition Therapeutics, Inc. (CGTX)

Cognition Therapeutics Statistics

Total Valuation

CGTX has a market cap or net worth of $146.45 million. The enterprise value is $107.50 million.

Market Cap	146.45M
Enterprise Value	107.50M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CGTX has 88.22 million shares outstanding. The number of shares has increased by 70.13% in one year.

Current Share Class	88.22M
Shares Outstanding	88.22M
Shares Change (YoY)	+70.13%
Shares Change (QoQ)	+22.39%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	15.85%
Float	87.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.01
P/TBV Ratio	4.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.44, with a Debt / Equity ratio of 0.01.

Current Ratio	6.44
Quick Ratio	6.20
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,450.08

Financial Efficiency

Return on equity (ROE) is -109.73% and return on invested capital (ROIC) is -107.88%.

Return on Equity (ROE)	-109.73%
Return on Assets (ROA)	-78.99%
Return on Invested Capital (ROIC)	-107.88%
Return on Capital Employed (ROCE)	-122.07%
Revenue Per Employee	n/a
Profits Per Employee	-$999,500
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +240.03% in the last 52 weeks. The beta is 1.23, so CGTX's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	+240.03%
50-Day Moving Average	1.79
200-Day Moving Average	0.90
Relative Strength Index (RSI)	48.73
Average Volume (20 Days)	1,370,940

Short Selling Information

The latest short interest is 8.44 million, so 9.56% of the outstanding shares have been sold short.

Short Interest	8.44M
Short Previous Month	7.14M
Short % of Shares Out	9.56%
Short % of Float	9.62%
Short Ratio (days to cover)	2.90

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.85M
Pretax Income	-27.99M
Net Income	-27.99M
EBITDA	-44.80M
EBIT	-44.85M
Earnings Per Share (EPS)	-$0.46

Balance Sheet

The company has $39.33 million in cash and $380,000 in debt, giving a net cash position of $38.95 million or $0.44 per share.

Cash & Cash Equivalents	39.33M
Total Debt	380,000
Net Cash	38.95M
Net Cash Per Share	$0.44
Equity (Book Value)	36.53M
Book Value Per Share	0.41
Working Capital	36.23M

Cash Flow

In the last 12 months, operating cash flow was -$29.53 million and capital expenditures -$1,000, giving a free cash flow of -$29.53 million.

Operating Cash Flow	-29.53M
Capital Expenditures	-1,000
Free Cash Flow	-29.53M
FCF Per Share	-$0.33

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.13%
Shareholder Yield	-70.13%
Earnings Yield	-19.11%
FCF Yield	-20.17%

Analyst Forecast

The average price target for CGTX is $2.83, which is 70.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.83
Price Target Difference	70.48%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-28.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1